Adamis Pharmaceuticals Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 2.68%43.960.9%$1092.30m
JNJJohnson & Johnson 0.09%172.360.7%$1089.22m
AZNAstraZeneca Plc 0.37%57.451.0%$986.82m
ABBVAbbVie, Inc. -0.25%116.021.9%$650.54m
MRKMerck & Co., Inc. -0.83%76.230.7%$646.80m
LLYEli Lilly & Co. 1.43%246.971.1%$586.48m
BMYBristol-Myers Squibb Co. 0.45%68.181.0%$582.58m
NRXPNRX Pharmaceuticals, Inc. 8.73%16.510.0%$182.48m
GSKGlaxoSmithKline Plc 0.37%40.290.2%$155.09m
NVSNovartis AG -0.02%92.380.2%$154.71m
RGENRepligen Corp. 0.80%247.676.8%$96.30m
VTRSViatris, Inc. 1.60%14.300.0%$87.70m
NVONovo Nordisk A/S 0.35%92.930.1%$81.67m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -5.08%119.610.0%$81.00m
SNYSanofi 0.03%51.580.2%$73.69m

Company Profile

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfuncti markets. The company was founded in June 2006 and is headquartered in San Diego, CA.